Joshua Moreau, Ph.D. (he/him)
- Assistant Professor of Division of Oncological Sciences, School of Medicine
- Assistant Professor of Dermatology, School of Medicine
- Assistant Professor of Cell, Developmental and Cancer Biology, School of Medicine
- Assistant Professor, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Biography
Joshua Moreau is an Assistant Professor in the Division of Oncological Sciences, Department of Dermatology, Department of Cell, Developmental & Cancer Biology, and a member of CEDAR. His laboratory seeks to explore the intersection between adaptive immune function and tissue biology. A major research focus is to understand how tissue resident lymphocytes in barrier organs, especially the skin, integrate microenvironmental signals during inflammatory disease and cancer. Combining multiomic approaches with functional immunology, this work investigates the basic biology of tissue resident lymphocytes and the role of these cells during disease pathogenesis. A long-term goal is to leverage these insights to develop new strategies for tissue specific immunotherapy. Prior to starting his lab at OHSU, Josh completed an Ph.D. in Immunology at the Princess Margaret Cancer Centre and University of Toronto before moving to the University of California, San Francisco for a postdoc in tissue specific immunity with Dr. Michael Rosenblum.
Education and training
-
Degrees
- Ph.D., University of Toronto
-
Fellowship
- Postdoctoral Fellowship, UCSF
Areas of interest
- tissue specific immunity
- adaptive immunity
- cutaneous immunology
- cancer immunotherapy
- melanoma
- B cells
- hidradenitis suppurativa
Honors and awards
- Melanoma Research Alliance Young Investigator, 2024-2027
- Human Frontier Science Program Fellow, 2018-2021
- Cancer Research Society SNGS Award, 2021
Publications
Publications
IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum
Journal of Investigative DermatologyRegulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche
Science ImmunologyTertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa
JCI InsightIdentifying and antagonizing the interactions between layilin and glycosylated collagens
Cell Chemical BiologyXenograft Skin Model to Manipulate Human Immune Responses In Vivo
Journal of Visualized ExperimentsLayilin anchors regulatory t cells in skin
Journal of ImmunologyRegulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation
Science ImmunologyA Blueprint for Identifying Phenotypes and Drug Targets in Complex Disorders with Empirical Dynamics
PatternsLayilin augments integrin activation to promote antitumor immunity
Journal of Experimental Medicinec-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells
Cell ReportsDifferential regulation of IgA + B cells in vitro by stromal cells from distinctive anatomical compartments
Journal of Leukocyte BiologyInflammatory T cells maintain a healing disposition
Science ImmunologyInterleukin-15 in cancer immunotherapy
Journal for immunotherapy of cancerRegulatory T cells in skin are uniquely poised to suppress profibrotic immune responses
Science ImmunologyBone marrow basophils provide survival signals to immature B cells in vitro but are dispensable in vivo
PloS oneTumor-secreted products repress B-cell lymphopoiesis in a murine model of breast cancer
European Journal of ImmunologyInflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses
BloodMurine splenic CD4⁺ T cells, induced by innate immune cell interactions and secreted factors, develop antileukemia cytotoxicity
Cancer Immunology Research